Ethical approval to conduct the study was obtained from the Kilimanjaro Christian Medical University College Ethical Committee (Ethical approval number 2039). Permission to carry out the study was obtained from the District Medical Officer (DMO) of Moshi Municipality and in-charge of selected health facilities. Written, informed consent was obtained from each participant. Confidentiality with regards to the information of the participants was highly maintained as no names appeared on the questionnaires. Participants who did not want to participate were not denied access to services at the health facilities. Participants with raise FBG of 7 mmol/L were referred to the diabetes clinic of their respective facility for further evaluation and management.

注意:以上内容是从某篇研究文章中自动提取的,可能无法正确显示。



Q&A
请登录并在线提交您的问题
您的问题将发布在Bio-101网站上。我们会将您的问题发送给本研究方案的作者和具有相关研究经验的Bio-protocol成员。我们将通过您的Bio-protocol帐户绑定邮箱进行消息通知。